Berlin’s pharmaceutical companies generate around 13 percent of the overall turnover in pharmaceuticals in Germany, making Berlin the capital of the pharmaceutical industry.
Why Berlin?
"Berlin has an excellent clinical and research landscape and is an attractive location for many reasons. We want to be successful as a pharmaceutical company, but we can only achieve this with dedicated and well-qualified staff, with the right partners, a good environment and the appropriate infrastructure. Berlin offers all of this."
Andreas Fibig, Member of the Bayer HealthCare Executive Committee and Head of the Pharmaceuticals DivisionBerlin has become one of the major and most attractive centers of the medical and health services industries in Germany. The colossal growth of the pharmaceuticals sector in the German capital makes this industry the driving force behind the upswing of the Berlin economy. In spite of the economic and financial crisis, the Berlin pharmaceuticals industry is seeing high turnover increases.
The following factors all work to benefit the sector:
An excellent environment for science and research
In increasing numbers, global players and medium-sized companies alike are moving to Berlin or relocating their headquarters to the German capital in order to put these advantages to the best possible use.
The exceptional opportunities for cooperating with renowned universities, research institutions and biotechnology companies are an excellent basis on which to pursue innovative projects for the future.
Currently, 23 pharmaceutical companies have their offices in Berlin, employing around 9,500 people.
URL: http://www.businesslocationcenter.de/en/B/iv/5/seite0.jsp